Toll-like receptors as potential therapeutic targets in cardiac dysfunction. - Wikidata - wikimedia - TriplyDB

Toll-like receptors as potential therapeutic targets in cardiac dysfunction.

Toll-like receptors as potential therapeutic targets in cardiac dysfunction.

http://www.wikidata.org/entity/Q37850809

about

Human myocardium releases heat shock protein 27 (HSP27) after global ischemia: the proinflammatory effect of extracellular HSP27 through toll-like receptor (TLR)-2 and TLR4 Can the TLR-4-mediated signaling pathway be "a key inflammatory promoter for sporadic TAA"?Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?How can we cure a heart "in flame"? A translational view on inflammation in heart failure.Toll-like receptors 2 and 4 modulate autonomic control of heart rate and energy metabolism Therapeutic targeting of Toll-like receptors in cutaneous disorders.MicroRNAs Association in the Cardiac Hypertrophy Secondary to Complex Congenital Heart Disease in Children.Synthetic CpG oligonucleotides induce a genetic profile ameliorating murine myocardial I/R injury.

P2860

Q33934579-23AACD43-4802-4260-82DC-5E7E84C08599 Q33996750-1EE523E8-204A-4CB5-9F1A-1660C6EEBE07 Q35678618-4474CF2A-0C1A-4B19-A1A4-3C314E24C5F6 Q37004826-EC57B934-EA38-4C5B-92AF-636C9C2CD23D Q37625913-AC714B5B-B297-4AEC-A116-A4593F8CA2A0 Q38550117-7D9CB396-F978-41DA-8CFB-824652FF4F48 Q50446253-03C6DA27-38A2-47C3-8692-276C5EEE84B9 Q55366238-3D16F46F-1358-4BC4-ACE3-CE1456D86BF0

P2860

Toll-like receptors as potential therapeutic targets in cardiac dysfunction.

http://www.wikidata.org/entity/Q37850809

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Toll-like receptors as potential therapeutic targets in cardiac dysfunction.

@en

Toll-like receptors as potential therapeutic targets in cardiac dysfunction.

@nl

type

label

Toll-like receptors as potential therapeutic targets in cardiac dysfunction.

@en

Toll-like receptors as potential therapeutic targets in cardiac dysfunction.

@nl

prefLabel

Toll-like receptors as potential therapeutic targets in cardiac dysfunction.

@en

Toll-like receptors as potential therapeutic targets in cardiac dysfunction.

@nl

P1433

Q37850809-FD861A29-C1C1-46D7-8EF9-3A559F90228E

P1476

Q37850809-98C10E72-2D2B-44BC-A46C-B693CAEC3671

P2093

Q37850809-791BBAC9-4026-430E-8222-C4FAD4C754D7

Q37850809-9A171B4B-B50F-42B2-BB3D-0BDA39E3F8E0

Q37850809-FE4F2C8A-59E3-4AC8-8821-D73657090113

P2860

Q37850809-045F18F5-729E-491B-939D-D3B441092B5F

Q37850809-04FF82BC-7FDC-446E-A9EF-FFEA0423A1E8

Q37850809-0A5E2721-191B-40B9-8B12-77528A093F1A

Q37850809-0A9050D0-FB43-4517-B8F2-E869E71005DD

Q37850809-0F78FFF9-FD84-4071-9DFE-22A2A86E1CE4

Q37850809-0FDBF84D-124C-4738-B4D7-FF1D7E371A5B

Q37850809-11C5AEB8-6BC7-433D-9191-AB93FCF23E61

Q37850809-12DF3266-06EF-4BA0-9DEF-ED541ED59654

Q37850809-13833AB9-EF34-458B-8134-6755AF804C8F

Q37850809-15C18C28-7EE9-4126-8E2D-4C9E540FCCE8

P304

Q37850809-B1E4A910-7DA1-46E2-9181-890F3AE20658

P31

Q37850809-D7274126-7FE7-4A96-8D53-9777092CCD9B

P356

Q37850809-D0757E40-4798-476F-9A77-3BE39D438959

P407

Q37850809-57B59DF1-B9D5-4BF7-BE9F-6D94163B2889

P433

Q37850809-1EA6F879-A646-4FE1-A2AE-4F09884725C4

P478

Q37850809-6F4B5FD2-D235-45D0-BF1A-4AE808951F85

P577

Q37850809-88BECBAA-E7E5-49CC-ACB3-ED036F58BA2E

P698

Q37850809-335A0DB2-B1E5-458D-9288-2DDB0405AED2

P921

Q37850809-09E06C54-5CEC-4D35-BD73-4D9F21C72D5F

P356

14728222.2011.566560

P1433

Expert Opinion on Therapeutic Targets

P1476

Toll-like receptors as potential therapeutic targets in cardiac dysfunction.

@en

P2093

Georg Ertl

http://www.w3.org/2001/XMLSchema#string

Stefan Frantz

http://www.w3.org/2001/XMLSchema#string

Ulrich Hofmann

http://www.w3.org/2001/XMLSchema#string

P2860

Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

The apoptotic signaling pathway activated by Toll-like receptor-2

Toll-like receptor family and signalling pathway

Toll-like receptor signalling

Pathogen recognition and innate immunity

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis

The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults

P304

753-765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2011.566560

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21385118

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor